SENORES1,468.00

Senores Pharmaceuticals Limited

· Pharma & Health
₹ CrorePeersSANOFIINNOVACAPMOREPENLABIOLCPFDCPGHLSANOFICONRORCHPHARMAMcap ₹6,760 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SENORES
FY26
SANOFI
FY25
INNOVACAP
FY26
MOREPENLAB
FY26
Peer
Median
Valuation — at last close
P/E55.63×17.33×47.30×66.76×47.30× +18%
P/B7.01×8.31×6.11×5.07×6.11× +15%
EV/EBITDA41.84×13.99×28.68×51.49×28.68× +46%
Market Cap₹6,760 Cr₹7,153 Cr₹6,667 Cr₹6,328 Cr₹6,667 Cr +1%
Growth
Revenue CAGR 3Y8.40%8.40%
Revenue CAGR 5Y8.73%8.73%
Net Income CAGR 3Y34.87%34.87%
Revenue YoY (latest Q)30.60%-25.80%33.94%34.07%33.94% -10%
Net Income YoY (latest Q)43.77%-33.70%42.27%424.73%42.27% +4%
Profitability
EBITDA Margin26.61%24.38%14.90%6.96%14.90% +79%
Net Income Margin19.21%20.53%8.65%5.25%8.65% +122%
Return on Common Equity12.60%48.02%12.92%7.61%12.92% -2%
Return on Capital Employed11.62%50.87%14.73%6.17%14.73% -21%
Return on Assets7.58%25.64%7.67%4.90%7.67% -1%
Credit & Quality
Total Debt/Equity0.34×0.00×0.32×0.16×0.16× +113%
Interest Coverage5.48×302.73×11.70×5.43×11.70× -53%
Scale — latest FY
Revenue / Total Income₹633 Cr₹2,013 Cr₹1,630 Cr₹1,806 Cr₹1,806 Cr -65%
Net Income₹122 Cr₹413 Cr₹141 Cr₹94.9 Cr₹141 Cr -14%
Total Assets₹1,604 Cr₹1,612 Cr₹1,837 Cr₹1,936 Cr₹1,837 Cr -13%
EPS₹26.39₹179.46₹24.63₹1.73₹24.63 +7%
Book Value per Share₹209.45₹374.17₹190.61₹22.76₹190.61 +10%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.